DBV Technologies (DBVT)
DBV Technologies on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq.
1.1M
Short interest
settlement 2026-09-30
3.9
Days to cover
+0.6 days vs prior
30.9%
Short share of volume
2026-10-23
1
Fails to deliver
settlement 2026-09-30
Wed 28 Oct
Next earnings
estimated date
-$1K
Insider flow, 90 days
0 buys, 1 sells
As of 2026-10-23.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in DBVT is 1,124,201 shares, down 459,723 shares over the last month. Over the last 48 readings it ranged from 10,930 shares (15 August 2025) to 1,848,774 shares (31 July 2026). At the reported average volume of 285K shares a day that is 3.9 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/dbvt" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 1,124,201 | -16.9% | 285,034 | 3.94 |
| 2026-09-15 | 1,353,244 | -14.6% | 410,543 | 3.30 |
| 2026-08-31 | 1,583,924 | -3.0% | 163,289 | 9.70 |
| 2026-08-14 | 1,633,383 | -11.7% | 411,320 | 3.97 |
| 2026-07-31 | 1,848,774 | +25.7% | 370,293 | 4.99 |
| 2026-07-15 | 1,470,719 | +13.2% | 187,661 | 7.84 |
| 2026-06-30 | 1,299,136 | -8.7% | 352,048 | 3.69 |
| 2026-06-15 | 1,423,044 | -14.6% | 259,294 | 5.49 |
| 2026-05-29 | 1,666,927 | -7.5% | 282,436 | 5.90 |
| 2026-05-15 | 1,801,328 | -0.8% | 179,255 | 10.05 |
| 2026-04-30 | 1,814,983 | +14.3% | 199,934 | 9.08 |
| 2026-04-15 | 1,587,873 | -6.0% | 246,418 | 6.44 |
| 2026-03-31 | 1,688,295 | +12.9% | 229,366 | 7.36 |
| 2026-03-13 | 1,495,666 | +12.8% | 334,950 | 4.47 |
| 2026-02-27 | 1,325,338 | +7.8% | 130,693 | 10.14 |
| 2026-02-13 | 1,230,049 | -2.0% | 347,931 | 3.54 |
| 2026-01-30 | 1,255,287 | +0.5% | 580,813 | 2.16 |
| 2026-01-15 | 1,248,971 | +40.1% | 363,667 | 3.43 |
| 2025-12-31 | 891,492 | +440.8% | 773,767 | 1.15 |
| 2025-12-15 | 164,840 | +411.4% | 670,538 | 1.00 |
| 2025-11-28 | 32,231 | -1.4% | 196,159 | 1.00 |
| 2025-11-14 | 32,706 | +50.6% | 81,985 | 1.00 |
| 2025-10-31 | 21,715 | +0.5% | 163,884 | 1.00 |
| 2025-10-15 | 21,598 | +15.5% | 223,195 | 1.00 |
| 2025-09-30 | 18,695 | +0.1% | 47,797 | 1.00 |
| 2025-09-15 | 18,674 | -0.6% | 28,903 | 1.00 |
| 2025-08-29 | 18,778 | +71.8% | 42,076 | 1.00 |
| 2025-08-15 | 10,930 | -6.1% | 28,147 | 1.00 |
| 2025-07-31 | 11,643 | -17.4% | 36,132 | 1.00 |
| 2025-07-15 | 14,088 | -23.5% | 23,277 | 1.00 |
| 2025-06-30 | 18,426 | -16.2% | 26,020 | 1.00 |
| 2025-06-13 | 21,988 | +6.9% | 27,655 | 1.00 |
| 2025-05-30 | 20,561 | -78.4% | 96,071 | 1.00 |
| 2025-05-15 | 95,156 | -40.6% | 98,585 | 1.00 |
| 2025-04-30 | 160,141 | -1.1% | 99,122 | 1.62 |
| 2025-04-15 | 161,893 | -71.2% | 122,775 | 1.32 |
| 2025-03-31 | 561,856 | +65.0% | 2,056,220 | 1.00 |
| 2025-03-14 | 340,543 | -6.3% | 24,018 | 14.18 |
| 2025-02-28 | 363,360 | -1.4% | 6,842 | 53.11 |
| 2025-02-14 | 368,653 | +3.0% | 42,721 | 8.63 |
| 2025-01-31 | 357,792 | -19.8% | 24,203 | 14.78 |
| 2025-01-15 | 446,295 | -1.2% | 269,200 | 1.66 |
| 2024-12-31 | 451,603 | -26.1% | 44,412 | 10.17 |
| 2024-12-13 | 611,381 | +66.7% | 673,625 | 1.00 |
| 2024-11-29 | 366,658 | -70.8% | 40,444 | 9.07 |
| 2024-11-15 | 1,256,483 | -5.9% | 78,208 | 16.07 |
| 2024-10-31 | 1,334,676 | +298.4% | 3,298,853 | 1.00 |
| 2024-10-15 | 335,001 | +4.2% | 41,601 | 8.05 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 23 October 2026, the short share of DBVT volume is 30.9%, up 9.6 points over the last five sessions. Over the last 30 readings it ranged from 5.8% (28 September 2026) to 80.3% (18 September 2026). The latest reading is 10.0 points below the 30-session average of 40.9%, on 62K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-23 | 19K | 62K | 30.9% | 400 |
| 2026-10-22 | 22K | 37K | 60.0% | 0 |
| 2026-10-21 | 24K | 49K | 50.2% | 300 |
| 2026-10-20 | 15K | 56K | 26.2% | 100 |
| 2026-10-19 | 26K | 138K | 18.6% | 6,223 |
| 2026-10-16 | 45K | 210K | 21.4% | 0 |
| 2026-10-15 | 23K | 148K | 15.2% | 100 |
| 2026-10-14 | 23K | 173K | 13.3% | 1,100 |
| 2026-10-13 | 47K | 100K | 46.8% | 200 |
| 2026-10-12 | 45K | 113K | 39.6% | 300 |
| 2026-10-09 | 45K | 173K | 25.8% | 500 |
| 2026-10-08 | 30K | 426K | 7.0% | 500 |
| 2026-10-07 | 56K | 158K | 35.4% | 7,800 |
| 2026-10-06 | 51K | 196K | 26.2% | 200 |
| 2026-10-05 | 23K | 95K | 24.2% | 100 |
| 2026-10-02 | 260K | 425K | 61.2% | 0 |
| 2026-10-01 | 93K | 129K | 72.0% | 100 |
| 2026-09-30 | 77K | 99K | 77.9% | 800 |
| 2026-09-29 | 30K | 52K | 57.4% | 600 |
| 2026-09-28 | 29K | 503K | 5.8% | 0 |
| 2026-09-25 | 66K | 113K | 58.4% | 900 |
| 2026-09-24 | 47K | 87K | 54.4% | 0 |
| 2026-09-23 | 27K | 89K | 30.1% | 0 |
| 2026-09-22 | 62K | 149K | 41.4% | 0 |
| 2026-09-21 | 20K | 37K | 53.4% | 0 |
| 2026-09-18 | 30K | 37K | 80.3% | 0 |
| 2026-09-17 | 18K | 34K | 53.7% | 0 |
| 2026-09-16 | 21K | 34K | 61.4% | 0 |
| 2026-09-15 | 26K | 51K | 51.3% | 0 |
| 2026-09-14 | 18K | 65K | 28.4% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 30 September 2026, the fails-to-deliver balance in DBVT is 1 share, down 12,782 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (30 September 2026) to 802,154 shares (14 September 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-30 | 1 | $11.55 | $12 |
| 2026-09-29 | 12,783 | $11.64 | $149K |
| 2026-09-25 | 6,340 | $11.60 | $74K |
| 2026-09-24 | 6,092 | $12.17 | $74K |
| 2026-09-23 | 5 | $12.63 | $63 |
| 2026-09-22 | 3,707 | $12.10 | $45K |
| 2026-09-18 | 15,780 | $12.51 | $197K |
| 2026-09-17 | 80,644 | $11.79 | $951K |
| 2026-09-16 | 2,155 | $11.76 | $25K |
| 2026-09-14 | 802,154 | $11.85 | $9.5M |
| 2026-09-08 | 131 | $13.47 | $2K |
| 2026-09-04 | 156 | $13.70 | $2K |
| 2026-09-02 | 4,301 | $13.42 | $58K |
| 2026-09-01 | 6,623 | $13.82 | $92K |
| 2026-08-31 | 10 | $13.54 | $135 |
| 2026-08-27 | 1,095 | $14.52 | $16K |
| 2026-08-19 | 5,078 | $14.47 | $73K |
| 2026-08-17 | 133 | $14.02 | $2K |
| 2026-08-12 | 10,000 | $14.09 | $141K |
| 2026-08-10 | 40,100 | $13.48 | $541K |
| 2026-08-07 | 122 | $13.74 | $2K |
| 2026-08-06 | 1,223 | $14.24 | $17K |
| 2026-08-05 | 27,320 | $13.71 | $375K |
| 2026-08-04 | 470 | $13.58 | $6K |
| 2026-07-29 | 3,123 | $13.50 | $42K |
| 2026-07-28 | 34 | $13.90 | $473 |
| 2026-07-24 | 1,497 | $13.86 | $21K |
| 2026-07-22 | 130 | $14.22 | $2K |
| 2026-07-17 | 260 | $14.86 | $4K |
| 2026-07-15 | 888 | $15.92 | $14K |
Insider trades
SEC Form 4, newest first. JSONInsiders at DBVT reported 1 open-market sell worth $1K in the last 90 days and no open-market buys. Latest filing: Mohideen Pharis (Chief Medical Officer) on 2026-07-29.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-07-29 | Mohideen Pharis | Chief Medical Officer | Sell | 464 | $2.70 | $1K | 145K |
| 2026-01-29 | Mohideen Pharis | Chief Medical Officer | Sell | 534 | $4.86 | $3K | 145K |
| 2025-12-18 | EPIC Bpifrance | Member of 10% owner group | Sell | 1.3M | $4.19 | $5.4M | 7.3M |
| 2025-12-17 | EPIC Bpifrance | Member of 10% owner group | Sell | 40K | $5.28 | $211K | 8.6M |
| 2025-12-17 | EPIC Bpifrance | Member of 10% owner group | Sell | 2.0M | $4.84 | $9.9M | 8.6M |
| 2025-11-21 | Trapp Kevin Michael | Chief Commercial Officer | Grant | 55K | $0.00 | $0 | 55K |
| 2025-11-21 | Boucinha Virginie | Chief Financial Officer | Grant | 32K | $0.00 | $0 | 70K |
| 2025-11-21 | Mohideen Pharis | Chief Medical Officer | Grant | 44K | $0.00 | $0 | 146K |
| 2025-11-21 | Mohideen Pharis | Chief Medical Officer | Sell | 2K | $2.77 | $4K | 102K |
| 2025-11-20 | Mohideen Pharis | Chief Medical Officer | Sell | 6K | $2.88 | $19K | 103K |
| 2025-07-29 | Mohideen Pharis | Chief Medical Officer | Sell | 464 | $2.22 | $1K | 110K |
| 2025-05-22 | Mohideen Pharis | Chief Medical Officer | Sell | 397 | $1.84 | $730 | 110K |
| 2025-01-30 | Mohideen Pharis | Chief Medical Officer | Sell | 600 | $0.85 | $510 | 111K |
| 2024-11-25 | Mohideen Pharis | Chief Medical Officer | Sell | 565 | $0.57 | $322 | 111K |
| 2024-11-22 | Mohideen Pharis | Chief Medical Officer | Sell | 342 | $0.53 | $181 | 112K |
| 2024-11-21 | Boucinha Virginie | Chief Financial Officer | Grant | 19K | $0.00 | $0 | 38K |
| 2024-11-21 | Mohideen Pharis | Chief Medical Officer | Sell | 2K | $0.54 | $1K | 112K |
| 2024-11-21 | Mohideen Pharis | Chief Medical Officer | Grant | 35K | $0.00 | $0 | 114K |
| 2024-07-29 | Mohideen Pharis | Chief Medical Officer | Sell | 2K | $0.98 | $2K | 79K |
| 2024-05-24 | Mohideen Pharis | Chief Medical Officer | Sell | 660 | $1.36 | $898 | 81K |
| 2024-05-22 | Mohideen Pharis | Chief Medical Officer | Sell | 382 | $1.38 | $527 | 82K |
| 2024-03-08 | Tasse Daniel | CHIEF EXECUTIVE OFFICER | Buy | 17K | $0.83 | $14K | 17K |
| 2024-02-06 | Ndu Adora | Director | Buy | 2K | $0.89 | $2K | 2K |
| 2023-11-22 | Mohideen Pharis | Chief Medical Officer | Sell | 2K | $1.74 | $4K | 82K |
| 2023-11-20 | Mohideen Pharis | Chief Medical Officer | Grant | 35K | $0.00 | $0 | 84K |
| 2023-11-20 | Boucinha Virginie | Chief Financial Officer | Grant | 19K | $0.00 | $0 | 19K |
| 2023-08-25 | MORRIS TIMOTHY E | Director | Buy | 12K | $1.52 | $18K | 12K |
| 2023-08-01 | SOLAND DANIEL B | Director | Buy | 15K | $1.62 | $24K | 20K |
| 2023-05-24 | Mohideen Pharis | Chief Medical Officer | Sell | 469 | $3.54 | $2K | 49K |
| 2022-11-24 | Mohideen Pharis | Chief Medical Officer | Sell | 2K | $2.88 | $5K | 50K |
| 2022-11-21 | Robitaille Sebastien | Chief Financial Officer | Grant | 8K | $0.00 | $0 | 37K |
| 2022-11-21 | Mohideen Pharis | Chief Medical Officer | Grant | 18K | $0.00 | $0 | 52K |
| 2022-07-29 | Mohideen Pharis | Chief Medical Officer | Grant | 10K | $0.00 | $0 | 34K |
| 2022-06-13 | Baker Bros. Advisors (GP) LLC | Director,TenPercentOwner | Grant | 1.3M | price not stated in the filing | not stated | 1.6M |
| 2022-06-13 | Baker Bros. Advisors (GP) LLC | Director,TenPercentOwner | Grant | 10.6M | price not stated in the filing | not stated | 14.6M |
| 2021-11-22 | Robitaille Sebastien | Chief Financial Officer | Grant | 5K | $0.00 | $0 | 29K |
| 2021-11-22 | Mohideen Pharis | Chief Medical Officer | Grant | 9K | $0.00 | $0 | 24K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first, 50 of 52 shown. JSON18 holders report 5% or more of DBVT in their latest filing, 4 on Schedule 13D (active intent). The largest reported stake is Julian C. Baker at 10.0% of the class (25,586,190 shares), filed 2026-01-14 for an event on 2026-01-12.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G/Ano. 2 | MPM BioImpact LLCinvestment adviser | 18.3M | 6.2% | 2026-06-30 |
| 2026-08-06 | 13G | Peter Kolchinskyparent holding company, individual | 18.3M | 5.8% | 2026-07-30 |
| 2026-08-06 | 13G | Rajeev Shahparent holding company, individual | 18.3M | 5.8% | 2026-07-30 |
| 2026-08-06 | 13G | RA Capital Healthcare Fund, L.P.partnership | 18.3M | 5.8% | 2026-07-30 |
| 2026-08-06 | 13G | RA Capital Management, L.P.investment adviser, partnership | 18.3M | 5.8% | 2026-07-30 |
| 2026-05-13 | 13G/Ano. 1 | Artisan Partners Asset Management Inc.parent holding company | 2.2M | 3.7% | 2026-03-31 |
| 2026-05-13 | 13G/Ano. 1 | Artisan Partners Limited Partnershipinvestment adviser | 2.2M | 3.7% | 2026-03-31 |
| 2026-05-13 | 13G/Ano. 1 | Artisan Investments GP LLCparent holding company | 2.2M | 3.7% | 2026-03-31 |
| 2026-05-13 | 13G/Ano. 1 | Artisan Partners Holdings LPparent holding company | 2.2M | 3.7% | 2026-03-31 |
| 2026-05-13 | 13G/Ano. 1 | Adage Capital Management, L.P.investment adviser, partnership | 22.3M | 7.3% | 2026-03-31 |
| 2026-05-13 | 13G/Ano. 1 | Phillip Grossparent holding company, individual | 22.3M | 7.3% | 2026-03-31 |
| 2026-05-13 | 13G/Ano. 1 | Robert Atchinsonparent holding company, individual | 22.3M | 7.3% | 2026-03-31 |
| 2026-05-12 | 13G/Ano. 2 | Vivo Opportunity, LLCother entity | 11.8M | 4.0% | 2026-03-31 |
| 2026-05-12 | 13G/Ano. 2 | Vivo Opportunity Fund Holdings, L.P.partnership | 11.8M | 4.0% | 2026-03-31 |
| 2026-05-12 | 13G/Ano. 2 | Vivo Opportunity Cayman, LLCother entity | 1.5M | 0.5% | 2026-03-31 |
| 2026-05-12 | 13G/Ano. 2 | Vivo Opportunity Cayman Fund, L.P.partnership | 1.5M | 0.5% | 2026-03-31 |
| 2026-05-05 | 13G/Ano. 2 | Raymond Debbaneindividual | 19.3M | 6.5% | 2026-03-31 |
| 2026-05-05 | 13G/Ano. 2 | Invus Global Management, LLCother entity | 18.0M | 6.1% | 2026-03-31 |
| 2026-05-05 | 13G/Ano. 2 | Siren, L.L.C.other entity | 18.0M | 6.1% | 2026-03-31 |
| 2026-05-05 | 13G/Ano. 2 | Invus Public Equities Advisors, LLCother entity | 18.0M | 6.1% | 2026-03-31 |
| 2026-05-05 | 13G/Ano. 2 | Invus Public Equities, L.P.partnership | 18.0M | 6.1% | 2026-03-31 |
| 2026-05-05 | 13G/Ano. 2 | Avicenna Life Sci Master GP LLCother entity | 1.3M | 0.4% | 2026-03-31 |
| 2026-05-05 | 13G/Ano. 2 | Avicenna Life Sci Master Fund LPpartnership | 1.3M | 0.4% | 2026-03-31 |
| 2026-05-05 | 13G/Ano. 2 | Ulys, L.L.C.other entity | 1.3M | 0.4% | 2026-03-31 |
| 2026-02-17 | 13G/Ano. 5 | VHCP Management II, LLCother entity | 0 | 0.0% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 5 | VHCP Co-Investment Holdings II, LLCother entity | 0 | 0.0% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 5 | Venrock Healthcare Capital Partners II, L.P.partnership | 0 | 0.0% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 5 | Bong Y. Kohindividual | 0 | 0.0% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 5 | Nimish Shahindividual | 0 | 0.0% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 5 | VHCP Management EG, LLCother entity | 0 | 0.0% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 5 | VHCP Management III, LLCother entity | 0 | 0.0% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 5 | Venrock Healthcare Capital Partners EG, L.P.partnership | 0 | 0.0% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 5 | VHCP Co-Investment Holdings III, LLCother entity | 0 | 0.0% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 5 | Venrock Healthcare Capital Partners III, L.P.partnership | 0 | 0.0% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | Kenneth Griffinparent holding company, individual | 8.1M | 3.5% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | Citadel GP LLCparent holding company, other entity | 7.4M | 3.1% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | Citadel Advisors Holdings LPparent holding company, partnership | 7.4M | 3.1% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | Citadel Advisors LLCinvestment adviser, parent holding company, other entity | 7.4M | 3.1% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | Citadel Securities Group LPparent holding company, partnership | 733K | 0.3% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | Citadel Securities GP LLCparent holding company, other entity | 733K | 0.3% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | Citadel Securities LLCbroker-dealer, other entity | 47K | 0.0% | 2025-12-31 |
| 2026-01-14 | 13D/Ano. 9 | Julian C. Bakerindividual, parent holding company | 25.6M | 10.0% | 2026-01-12 |
| 2026-01-14 | 13D/Ano. 9 | Felix J. Bakerindividual, parent holding company | 25.6M | 10.0% | 2026-01-12 |
| 2026-01-14 | 13D/Ano. 9 | Baker Bros. Advisors (GP) LLCparent holding company, other entity | 25.6M | 10.0% | 2026-01-12 |
| 2026-01-14 | 13D/Ano. 9 | Baker Bros. Advisors LPinvestment adviser, partnership | 25.6M | 10.0% | 2026-01-12 |
| 2026-01-08 | 13G/Ano. 2 | JANUS HENDERSON GROUP PLCinvestment adviser, parent holding company | 20.5M | 8.8% | 2025-12-31 |
| 2026-01-07 | 13D/Ano. 10 | Bpifrance S.A.other entity | 10.9M | 4.7% | 2026-01-05 |
| 2026-01-07 | 13D/Ano. 10 | EPIC Bpifranceother entity | 10.9M | 4.7% | 2026-01-05 |
| 2026-01-07 | 13D/Ano. 10 | Caisse des Depotsother entity | 10.9M | 4.7% | 2026-01-05 |
| 2026-01-07 | 13D/Ano. 10 | Bpifrance Participations S.A.other entity | 10.7M | 4.6% | 2026-01-05 |
13F holders
Tracked managers holding DBVT at their latest 13F. JSON5 of the 30 tracked managers held DBVT at their latest 13F, $11.4M in total at quarter-end prices. Duquesne Family Office is the largest at $6.3M (0.1% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 1 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Duquesne Family Office | 2026-06-30 | 383K | $6.3M | 0.12% | 0 |
| Millennium Management | 2026-06-30 | 268K | $4.4M | 0.00% | -51K |
| Citadel Advisors | 2026-06-30 | 23K | $374K | 0.00% | new |
| Point72 Asset Management | 2026-06-30 | 12K | $199K | 0.00% | new |
| Two Sigma Investments | 2026-06-30 | 12K | $191K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
DBV Technologies in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows DBV Technologies (DBVT), SEC CIK 1613780, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-23.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-30.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-07-16.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-07-29.JSON and CSV
- Company record
- EDGAR filing index for CIK 1613780Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other company pages
- MLMMartin Marietta Materials
- MMM3M
- MNSTMonster Beverage
- MOAltria Group
- MODModine Manufacturing
- MOSMosaic
- MPMP Materials
- MPCMarathon Petroleum
- MPWRMonolithic Power Systems
- MRKMerck
- MRNAModerna
- MRSHMarsh & McLennan Companies
- MRVLMarvell Technology
- MSMorgan Stanley
- MSCIMSCI
- MSFTMicrosoft
- MSIMotorola Solutions
- MSTRStrategy
- MTBM&T Bank
- MTCHMatch Group
- MTDMettler-Toledo International
- MTNVail Resorts
- MTSIMACOM Technology Solutions Holdings
- MTZMasTec
Datasets
Frequently Asked Questions
How much of DBVT is sold short?
1,124,201 shares were held short at the 2026-09-30 settlement, 3.9 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is DBVT's daily short volume?
On 2026-10-23, 19,176 of the 61,948 DBVT shares reported to FINRA were sold short, 30.9% of the day's reported volume. Short volume is a flow for one day, not a position.
Does DBVT have fails to deliver?
The SEC's latest file shows 1 DBVT shares failed to deliver at settlement 2026-09-30. Fails are reported per settlement date and published twice a month with a lag.
Are DBVT insiders buying or selling?
Insiders at DBVT reported 1 open-market sell worth $1K in the last 90 days and no open-market buys. Latest filing: Mohideen Pharis (Chief Medical Officer) on 2026-07-29.
Who owns 5% or more of DBVT?
18 holders report 5% or more of DBVT in their latest filing, 4 on Schedule 13D (active intent). The largest reported stake is Julian C. Baker at 10.0% of the class (25,586,190 shares), filed 2026-01-14 for an event on 2026-01-12.
Which tracked 13F managers own DBVT?
5 of the 30 tracked 13F managers held DBVT shares at their latest filing, $11.4M in all. The largest: Stanley Druckenmiller's Duquesne Family Office (383K shares, $6.3M), Izzy Englander's Millennium Management (268K shares, $4.4M), Ken Griffin's Citadel Advisors (23K shares, $374K), Steve Cohen's Point72 Asset Management (12K shares, $199K), Two Sigma Investments (12K shares, $191K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.